Dexcom recalled its continuous glucose monitoring systems, which are used to monitor blood sugar levels of patients with type 1 or 2 diabetes.

An updated statement from the U.S. Preventive Services Task Force (USPSTF) recommends healthcare professionals initiate daily, low-dose aspirin for primary prevention of cardiovascular disease and colorectal cancer in adults who are between 50 and 59 years old and have a 10 percent or greater 10-year cardiovascular disease risk.

At the ACC scientific session earlier this month, FDA commissioner Robert Califf, MD, outlined a future that he envisions will include more of an emphasis on training doctors to understand the importance of data analysis and understanding cost considerations.

After reviewing current guidelines, researchers have found a lack of evidence to guide clinical decision making in older adults with cardiovascular disease and a lack of data on the impact diagnostic and therapeutic interventions have on quality of life, physical function and other outcomes.

Cardiologist Eric Topol, MD, and other leading physicians and researchers have criticized the New England Journal of Medicine in recent months, and now the journal's editor-in-chief has offered a response.

After 24 weeks, patients with a history of muscle-related statin intolerance and high levels of low-density lipoprotein (LDL) cholesterol who received evolocumab had significant reductions in LDL cholesterol compared with patients who received ezetimibe. In addition, 42.6 percent of patients with muscle-related statin intolerance experienced symptoms after taking 20 mg of atorvastatin.

CHICAGO – FDA commissioner Robert M. Califf, MD, stressed the importance of relying on data and evidence when approving medications and creating guidelines during a session at the ACC scientific session on April 4.

Since 2011, the prices of the top 10 medications in the U.S. each increased more than 50 percent, according to a Reuters analysis.